Weinberg Uri (CIK 1811030) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-05). Recent activity: Buy NVCR (50,125 shares), Sell NVCR (6,412 shares), Sell NVCR (7,461 shares), Buy NVCR (12,992 shares), Sell NVCR (3,272 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-05 | NovoCure Ltd (NVCR) | Chf Medical and Innovation Ofr | Buy | 50,125 | $0 |
| 2026-03-05 | NovoCure Ltd (NVCR) | Chf Medical and Innovation Ofr | Sell | 6,412 | $85,344 |
| 2026-03-03 | NovoCure Ltd (NVCR) | Chf Medical and Innovation Ofr | Sell | 7,461 | $103,260 |
| 2026-03-03 | NovoCure Ltd (NVCR) | Chf Medical and Innovation Ofr | Buy | 12,992 | $0 |
| 2026-03-03 | NovoCure Ltd (NVCR) | Chf Medical and Innovation Ofr | Sell | 3,272 | $43,616 |
| 2025-03-06 | NovoCure Ltd (NVCR) | Chief Innovation Officer | Buy | 54,975 | $999,995 |
| 2025-03-04 | NovoCure Ltd (NVCR) | Chief Innovation Officer | Sell | 268 | $5,071 |
| 2025-03-03 | NovoCure Ltd (NVCR) | Chief Innovation Officer | Sell | 4,326 | $81,242 |
| 2025-03-03 | NovoCure Ltd (NVCR) | Chief Innovation Officer | Sell | 311 | $5,694 |
| 2025-03-03 | NovoCure Ltd (NVCR) | Chief Innovation Officer | Sell | 4,326 | $81,242 |
| 2025-03-03 | NovoCure Ltd (NVCR) | Chief Innovation Officer | Sell | 311 | $5,694 |
Source: SEC Form 4 filings · as of 2026-03-05